DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

@article{Hessels2003DD3PCA3basedMU,
  title={DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.},
  author={D. Scott Hessels and Jacqueline M T Klein Gunnewiek and Inge M van Oort and Herbert F. M. Karthaus and Geert J. L. H. van Leenders and Bianca van Balken and Lambertus A Kiemeney and Johannes Alfred Witjes and Jack A Schalken},
  journal={European urology},
  year={2003},
  volume={44 1},
  pages={8-15; discussion 15-6}
}
BACKGROUND DD3(PCA3) is the most prostate cancer-specific gene described to date. To assess the clinical utility of DD3(PCA3) a time-resolved fluorescence-based, quantitative RT-PCR analysis for DD3(PCA3) was developed. METHODS The diagnostic potential of DD3(PCA3) was determined by quantitative measurement of DD3(PCA3) transcripts in non-malignant and malignant prostate specimens. Moreover, DD3(PCA3) transcripts were determined quantitatively in urine sediments obtained after prostatic… CONTINUE READING
Highly Influential
This paper has highly influenced 11 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
184 Extracted Citations
32 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 184 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 32 references

A time - resolved fluorescence - based determination of DD 3 PCA 3 mRNA : a new sensitive tool for prostate cancer diagnosis

  • C Auffray, F Rougeon
  • Submitted
  • 2003

The expression of a variant prostate - specific antigen in human prostate

  • TJ Polascik, JE Oesterling, AW Partin
  • Cancer Epidemiol Biomarkers Prev
  • 2002

Similar Papers

Loading similar papers…